Researchers at Thomas Jefferson University have developed an automated machine learning (AutoML) model that can accurately ...

It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.

HARRISONBURG, Va. (WHSV) - Irina Tsiberman, the wife of Spotswood High School Girls Junior Varsity soccer coach, Treyvon Medley-Green, is continuing to recover not only after giving birth, but also ...

Introduction: Robotic-assisted thoracoscopic surgery (RATS) in children remains a challenge, particularly in oncological cases. This study aims to provide practical and useful insights to enhance the ...

Celebrity medium Tyler Henry is recovering after undergoing his second surgery in six months to treat a cyst growing on his brain. The Life After Death star’s husband Clint Godwin announced on Friday ...

Tyler Henry is hoping for healing. The celebrity medium’s husband Clint Godwin shared that Tyler recently underwent a third brain operation—his second in six months—to address a cyst that had been ...

Tyler Henry, star of Hollywood Medium, has undergone his third brain surgery—and second this year—due to recurring symptoms from a colloid tumor. His husband, Clint Godwin, shared updates on social ...

The celebrity medium’s husband Clint Godwin shared that Tyler recently underwent a third brain operation—his second in six months—to address a cyst that had been growing and releasing fluid in his ...

FOG-001 targets the β-catenin–TCF interaction, a previously "undruggable" target, offering new hope for desmoid tumor treatment. Early clinical trials show FOG-001 leads to significant tumor shrinkage ...

Explore the critical role of biomarkers in diagnosing desmoid tumors and the importance of early detection for patient quality of life.

FOG-001 has been granted FDA fast track designation for desmoid tumors, expediting its development and review process. Preliminary trial data show FOG-001's significant antitumor activity, with an 80% ...

Milestone follows disclosure of compelling preliminary data presented at the ESMO Congress and the CTOS 2025 Annual Meeting showing clinically meaningful anti-tumor activity in desmoid tumors ...